In an adult with normal liver function and recurrent tinea corporis, is a weekly dosing schedule of terbinafine appropriate?

Weekly Dosing of Terbinafine for Tinea Corporis

No, weekly dosing of terbinafine is not appropriate for tinea corporis in adults—standard daily dosing of 250 mg for 2-4 weeks is the established regimen, and the FDA-approved label specifies daily dosing only for onychomycosis, not for tinea corporis. 1

Standard Dosing for Tinea Corporis

The evidence clearly supports daily dosing for tinea corporis:

• Short-term daily therapy (1-2 weeks) of terbinafine 250 mg once daily has proven highly effective for tinea corporis/cruris, with excellent mycological cure rates 2, 3
• One study demonstrated that even 2-3 days of consecutive daily dosing at 250 mg achieved good responses in tinea corporis/cruris 4
• The typical recommended duration is 2-4 weeks of daily therapy for body ringworm infections

Why Weekly Dosing Is Not Recommended

Weekly or pulse dosing regimens have only been studied and validated for onychomycosis, not for tinea corporis:

• The British Association of Dermatologists guidelines mention that "intermittent dosing regimens are effective" but this statement appears in the context of tinea capitis only, not tinea corporis 5
• Pulse therapy studies (weekly dosing) specifically evaluated onychomycosis where the drug accumulates in nail tissue over extended periods 6, 7
• The FDA label for terbinafine only approves daily dosing for onychomycosis (6 weeks for fingernails, 12 weeks for toenails) and does not mention weekly dosing for any indication 1

Critical Considerations for Recurrent Tinea Corporis

Since your patient has recurrent infection, consider these important factors:

Emerging resistance patterns:

• Recent data shows alarming terbinafine resistance, particularly with Trichophyton mentagrophytes strains (33% with high MICs) 8
• SQLE gene mutations (F397L, I479T, I479V) are associated with terbinafine resistance 8, 9
• Prior terbinafine exposure increases resistance risk 8

For recurrent cases, the appropriate approach is:

1. Confirm diagnosis with KOH and culture before retreating 10
2. Use standard daily dosing (250 mg daily for 2-4 weeks), not weekly dosing
3. Consider antifungal susceptibility testing if available, given recurrence 8
4. Combine with topical antifungals (e.g., clotrimazole, miconazole) for better outcomes 11
5. Continue treatment until mycological cure, not just clinical improvement 10
6. If treatment fails, consider itraconazole as second-line (better activity against resistant strains) 8, 9

Common Pitfalls to Avoid

• Do not use weekly dosing for tinea corporis—this extrapolates inappropriately from onychomycosis data
• Avoid combination antifungal-corticosteroid products as they promote resistance and worsen outcomes 10
• Do not stop treatment when lesions improve clinically; continue until mycological clearance 10
• Screen for reinfection sources (contaminated clothing, family members, pets)

The recurrence pattern suggests either inadequate initial treatment duration, reinfection, or possibly emerging resistance—not a need for weekly dosing, which lacks evidence for this indication.